Wednesday, July 8, 2026

pharma · Waldenstrom Macroglobulinemia · Non Small Cell Lung Cancer · CLRB

Cellectar Biosciences

NovaPharmaNews editorial coverage mentioning Cellectar Biosciences — regulatory, clinical, and market analysis.

100 Campus Dr, 207, Florham Park, New Jersey 07932, US HQ
21 Employees
Public company Type
CLRB · NYSE Ticker
Company details
Status
Public
HQ
100 Campus Dr, 207, Florham Park, New Jersey 07932, US
Employees
21
Programs
17
Drugs
7
Patents
7
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Cellectar Biosciences — regulatory, clinical, and market coverage.

NovaPharmaNews editorial coverage mentioning Cellectar Biosciences — regulatory, clinical, and market analysis.

No coverage yet

We have not published news or analysis mentioning Cellectar Biosciences yet.

Back to company overview →